Ozagrel hydrochloride
 OpenBabel02212023462D

 18 18  0  0  0  0  0  0  0  0999 V2000
   -0.9666    0.9101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2522    1.3226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4623    0.9101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4623    0.0851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2522   -0.3274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9666    0.0851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6811   -0.3274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6811   -1.1524    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0137   -1.6373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2686   -2.4220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0936   -2.4220    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3485   -1.6373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1768    1.3226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8912    0.9101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6057    1.3226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6057    2.1476    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3202    0.9101    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5595    0.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  6  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  2  0  0  0  0
  3 13  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 12  1  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 17  1  0  0  0  0
M  END
>  <CdId>
1991

>  <Mol Weight>
264.708

>  <Formula>
C13H13ClN2O2

>  <ID>
T6625

>  <Name>
Ozagrel hydrochloride

>  <Synonyms>
OKY-046 HCl

>  <CAS>
78712-43-3

>  <Approved status>
PMDA

>  <Disease>
Respiratory system/Metabolism/Cerebrovascular system

>  <Indication>
Asthma; Cerebral Vasospasm; Diabetic Nephropathies; Intracranial Thrombosis

>  <Pathways>
Others

>  <Target>
Thrombin inhibitor

>  <Receptor>
Thromboxane A2 synthetase

$$$$
